SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-210805
Filing Date
2014-05-23
Accepted
2014-05-23 09:04:07
Documents
9
Period of Report
2014-05-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d731823d8k.htm 8-K 23132
2 EX-1.1 d731823dex11.htm EX-1.1 31503
3 EX-4.1 d731823dex41.htm EX-4.1 77408
4 EX-4.2 d731823dex42.htm EX-4.2 8073
5 EX-5.1 d731823dex51.htm EX-5.1 8320
6 EX-10.1 d731823dex101.htm EX-10.1 182856
7 EX-10.2 d731823dex102.htm EX-10.2 108459
8 GRAPHIC g731823ex1_1pg01.jpg GRAPHIC 11755
9 GRAPHIC g731823ex5_1pg001.jpg GRAPHIC 6182
  Complete submission text file 0001193125-14-210805.txt   465948
Mailing Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 650-635-7000
OXIGENE INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21990 | Film No.: 14865552
SIC: 2836 Biological Products, (No Diagnostic Substances)